ArticleAmerican journal of translational research2022
Effect of care intervention based on susceptible pointers of care quality in patients with hepatic cerebropathy.
Article in American journal of translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the effect of care intervention based on susceptible pointers of care quality in patients with hepatic cerebropathy.
methodsThe clinical data of 106 patients with hepatic cerebropathy from January 2020 to June 2021 were retrospectively analyzed, and they were assigned to a study group (n=53) or a control group (n=53) in line with diverse care means. The control group received conventional care, and the study group received additional care intervention based on susceptible pointers of care quality. The liver function, blood ammonia, neural function, capacity of daily life, and quality of life were observed and contrasted in the two groups before and after the intervention. The implementation or occurrence of key indicators of care quality, the occurrence of adverse care events, and patient care satisfaction rate were documented in the two groups after intervention.
resultsAfter the intervention, the liver function, neural function, capacity of everyday activities, quality of life and the implementation or occurrence of key pointers of care quality in the study group were superior to those in the control group (P<0.05). The blood ammonia and the incidence of adverse events in the study group were lower than those of the control group (P<0.05), and the care satisfaction rate of patients in the study group was higher than that of the control group (P<0.05).
conclusionCare intervention based on susceptible pointers of care quality can help patients with hepatic cerebropathy to enhance liver and neural function, decrease blood ammonia and have fewer adverse care events, and enhances quality of life, care quality, and care satisfaction of patients.
Indexed as
Identifiers
35836888PMC9274580What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.